Beranda › Kolitis Ulseratif › Kansas › Kansas City
Uji klinis Kolitis Ulseratif di Kansas City, KS
6 studi untuk Kolitis Ulseratif mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Menerima pesertaFase 2
- Site 006, Kansas City
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Menerima pesertaFase 2
- University of Kansas Medical Center ( Site 1077), Kansas City
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- University of Kansas Cancer Center, Kansas City
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Menerima pesertaFase 4
- University of Kansas Medical Center, Kansas City
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Menerima pesertaFase 2
- University of Kansas Medical Center, Kansas City
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
- University of Kansas Medical Center - Site Number: 8400110, Kansas City
Uji klinis Kolitis Ulseratif di kota lain
- New York City, NY23 studi
- Orlando, FL22 studi
- Miami, FL21 studi
- Houston, TX17 studi
- San Antonio, TX16 studi
- Chicago, IL15 studi
- Tacoma, WA15 studi
- San Diego, CA15 studi
- Tyler, TX14 studi
- Colorado Springs, CO14 studi
- Los Angeles, CA13 studi
- St. Louis, MO13 studi
Studi lain di Kansas City
- Penyakit Kardiovaskular14 studi
- Penyakit Paru Interstisial13 studi
- Gagal Jantung13 studi
- Obesitas13 studi
- Fibrosis Kistik13 studi
- Kanker Kandung Kemih12 studi
- Kanker Prostat12 studi
- Kanker Payudara12 studi
- Kanker Paru Non-Sel Kecil11 studi
- Leukemia Mieloid Akut11 studi
- Kanker Paru11 studi
- PPOK9 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.